These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21197601)

  • 21. General principles for risk assessment of living modified organisms: lessons from chemical risk assessment.
    Hill RA; Sendashonga C
    Environ Biosafety Res; 2003; 2(2):81-8. PubMed ID: 15612274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging international regulatory framework for biotechnology.
    Komen J
    GM Crops Food; 2012; 3(1):78-84. PubMed ID: 22430851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. See what you eat--broad GMO screening with microarrays.
    von Götz F
    Anal Bioanal Chem; 2010 Mar; 396(6):1961-7. PubMed ID: 19862507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New trends in bioanalytical tools for the detection of genetically modified organisms: an update.
    Michelini E; Simoni P; Cevenini L; Mezzanotte L; Roda A
    Anal Bioanal Chem; 2008 Oct; 392(3):355-67. PubMed ID: 18537027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment for release of genetically modified organisms: a virus to reduce the fertility of introduced wild mice, Mus domesticus.
    Williams CK
    Reprod Suppl; 2002; 60():81-8. PubMed ID: 12220167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 9th International Symposium on the Biosafety of Genetically Modified Organisms. Session VII: Risk management and monitoring.
    Schiemann J
    Environ Biosafety Res; 2006; 5(4):201-3. PubMed ID: 17640508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public health issues related with the consumption of food obtained from genetically modified organisms.
    Paparini A; Romano-Spica V
    Biotechnol Annu Rev; 2004; 10():85-122. PubMed ID: 15504704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GMOtrack: generator of cost-effective GMO testing strategies.
    Novak PK; Gruden K; Morisset D; Lavrac N; Stebih D; Rotter A; Zel J
    J AOAC Int; 2009; 92(6):1739-46. PubMed ID: 20166592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Options to Reform the European Union Legislation on GMOs: Risk Governance.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Apr; 38(4):349-351. PubMed ID: 32171418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Debate on GMOs health risks after statistical findings in regulatory tests.
    de Vendômois JS; Cellier D; Vélot C; Clair E; Mesnage R; Séralini GE
    Int J Biol Sci; 2010 Oct; 6(6):590-8. PubMed ID: 20941377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The precautionary principle and genetically modified organisms: A bone of contention between European institutions and member states.
    Guida A
    J Law Biosci; 2021; 8(1):lsab012. PubMed ID: 34040782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DTREEv2, a computer-based support system for the risk assessment of genetically modified plants.
    Pertry I; Nothegger C; Sweet J; Kuiper H; Davies H; Iserentant D; Hull R; Mezzetti B; Messens K; De Loose M; de Oliveira D; Burssens S; Gheysen G; Tzotzos G
    N Biotechnol; 2014 Mar; 31(2):166-71. PubMed ID: 24308933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plants Developed by New Genetic Modification Techniques-Comparison of Existing Regulatory Frameworks in the EU and Non-EU Countries.
    Eckerstorfer MF; Engelhard M; Heissenberger A; Simon S; Teichmann H
    Front Bioeng Biotechnol; 2019; 7():26. PubMed ID: 30838207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of potentially hazardous human gene products in GMO risk assessment.
    Bergmans H; Logie C; Van Maanen K; Hermsen H; Meredyth M; Van Der Vlugt C
    Environ Biosafety Res; 2008; 7(1):1-9. PubMed ID: 18384725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
    Haslberger AG
    J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of GMOs in China.
    Liu Y
    J Int Bioethique; 2008 Dec; 19(4):139-58, 167. PubMed ID: 19492727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of a direct hybridization microarray strategy for comprehensive monitoring of genetically modified organisms (GMOs).
    Turkec A; Lucas SJ; Karacanli B; Baykut A; Yuksel H
    Food Chem; 2016 Mar; 194():399-409. PubMed ID: 26471572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationalizing the GMO Debate: The Ordonomic Approach to Addressing Agricultural Myths.
    Hielscher S; Pies I; Valentinov V; Chatalova L
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27171102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.